
Paul Hudson
Vermögen: 700 705 $ am 30.09.2026

Vermögen: 700 705 $ am 30.09.2026
Herr Paul Hudson ist Chief Executive Officer & Director bei Sanofi, Chairman bei Novartis Pharma KK und Chief Executive Officer & Director bei Sanofi Clir SENC. Er ist Mitglied des Board of Directors bei Sanofi und Sanofi Clir SENC. Herr Hudson war zuvor als Chief Executive Officer bei Novartis Pharmaceuticals Corp., als President-AstraZeneca US & EVP-North America bei AstraZeneca Plc, als President bei AstraZneca Farmacutica Spain SA, als President & Director bei AstraZeneca KK, als Member-Executive Committee bei Novartis AG und als Head-Global Marketing bei Schering Plough Holdings France SAS tätig. Er erhielt seinen Bachelor-Abschluss an der Manchester Metropolitan University of.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.10.2026 | 6.139 ( 0 % ) | 700 705 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Direktor/Vorstandsmitglied | 20.10.2026 |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Vorstandsvorsitzender | 17.02.2026 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Vorstandsvorsitzender | 01.01.2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.06.2016 |
Schering Plough Holdings France SAS
Schering Plough Holdings France SAS Pharmaceuticals: OtherHealth Technology Manufactures healthcare products and medicines | Vertrieb & Marketing | - |
Sanofi Clir SNC
Sanofi Clir SNC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Manchester Metropolitan University
Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Health Technology |
AstraZéneca Farmacéutica Spain SA
AstraZéneca Farmacéutica Spain SA Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Schering Plough Holdings France SAS
Schering Plough Holdings France SAS Pharmaceuticals: OtherHealth Technology Manufactures healthcare products and medicines | Health Technology |
Sanofi Clir SNC
Sanofi Clir SNC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen